Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)

v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Revenue $ 5,467 $ 4,827
Operating expenses:    
Research and development 25,171 20,029
General and administrative 6,949 5,739
Total operating expenses 32,120 25,768
Loss from operations (26,653) (20,941)
Interest income 35 10
Interest expense (976) (967)
Change in fair value of warrant liability 2,448 7,670
Net loss applicable to common stockholders $ (25,146) $ (14,228)
Net loss per share applicable to common stockholders - basic and diluted $ (0.40) $ (0.23)
Weighted-average number of common shares used in net loss per share applicable to common stockholders - basic and diluted 63,061,423 61,379,641